SEC Form 4 · accession 0001213900-19-003447
LifeMD, Inc. · LFMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert L Kalkstein
Officer — Chief Financial Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 4, 2019 · 6:03 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000948320
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase Common Stock | $0.28 | Oct 1, 2017 | J | 150,000 | A | Oct 1, 2017 | Sep 30, 2027 | Common Stock | 150,000 | 150,000 | D |
| Options to purchase Common Stock | $0.28 | Mar 1, 2019 | J | 150,000 | A | Mar 31, 2019 | Sep 30, 2027 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1These options were previously reported by Mr. Kalkstein on his Form 3 filed with the Commission on November 13, 2017. Pursuant to an amendment to his consulting agreement with Conversion Labs, Inc., the exercise price of these options were reduced from $0.40 to $0.28.
- F2Pursuant to an amendment to his consulting agreement with Conversion Labs, Inc., the exercise price of these options were reduced from $0.40 to $0.28 and now vest on March 31, 2019. Additionally, the 200,000 to be issued to Mr. Kalkstein pursuant to his consulting agreement were cancelled and Mr. Kalkstein also has forgone $32,500 owed to him by Conversion Labs, Inc.